• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多机构癌症患者对补充和替代医学信息来源的接触、认知和信任的分析。

Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine.

机构信息

Department of Radiation Oncology, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, UT.

Department of Communication, University of Utah, Salt Lake City, UT.

出版信息

JCO Oncol Pract. 2023 Nov;19(11):1000-1008. doi: 10.1200/OP.23.00179. Epub 2023 Sep 18.

DOI:10.1200/OP.23.00179
PMID:37722084
Abstract

PURPOSE

Complementary and alternative medicine (CAM) use during cancer treatment is controversial. We aim to evaluate contemporary CAM use, patient perceptions and attitudes, and trust in various sources of information regarding CAM.

METHODS

A multi-institutional questionnaire was distributed to patients receiving cancer treatment. Collected information included respondents' clinical and demographic characteristics, rates of CAM exposure/use, information sources regarding CAM, and trust in each information source. Comparisons between CAM users and nonusers were performed with chi-squared tests and one-way analysis of variance. Multivariable logistic regression models for trust in physician and nonphysician sources of information regarding CAM were evaluated.

RESULTS

Among 749 respondents, the most common goals of CAM use were management of symptoms (42.2%) and treatment of cancer (30.4%). Most CAM users learned of CAM from nonphysician sources. Of CAM users, 27% reported not discussing CAM with their treating oncologists. Overall trust in physicians was high in both CAM users and nonusers. The only predictor of trust in physician sources of information was income >$100,000 in US dollars per year. Likelihood of trust in nonphysician sources of information was higher in females and lower in those with graduate degrees.

CONCLUSION

A large proportion of patients with cancer are using CAM, some with the goal of treating their cancer. Although patients are primarily exposed to CAM through nonphysician sources of information, trust in physicians remains high. More research is needed to improve patient-clinician communication regarding CAM use.

摘要

目的

癌症治疗过程中补充和替代医学(CAM)的使用存在争议。我们旨在评估当代 CAM 的使用情况、患者的看法和态度,以及对各种 CAM 信息来源的信任程度。

方法

我们向接受癌症治疗的患者分发了多机构问卷。收集的信息包括受访者的临床和人口统计学特征、CAM 暴露/使用率、CAM 相关信息来源以及对每种信息来源的信任度。使用卡方检验和单向方差分析比较 CAM 用户和非用户。评估了对医生和非医生 CAM 信息来源的信任的多变量逻辑回归模型。

结果

在 749 名受访者中,CAM 使用的最常见目标是控制症状(42.2%)和治疗癌症(30.4%)。大多数 CAM 用户从非医生来源了解 CAM。在 CAM 用户中,有 27%的人未与他们的治疗肿瘤学家讨论 CAM。CAM 用户和非用户对医生的总体信任度都很高。对医生信息来源的信任度唯一的预测因素是每年的收入超过 10 万美元。对非医生信息来源的信任度在女性中更高,而在具有研究生学历的人群中则更低。

结论

很大一部分癌症患者正在使用 CAM,其中一些人是为了治疗癌症。尽管患者主要通过非医生的信息来源接触 CAM,但对医生的信任度仍然很高。需要进一步研究以改善医患之间关于 CAM 使用的沟通。

相似文献

1
Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine.多机构癌症患者对补充和替代医学信息来源的接触、认知和信任的分析。
JCO Oncol Pract. 2023 Nov;19(11):1000-1008. doi: 10.1200/OP.23.00179. Epub 2023 Sep 18.
2
Determinants of public trust in complementary and alternative medicine.公众对补充和替代医学信任的决定因素。
BMC Public Health. 2010 Mar 12;10:128. doi: 10.1186/1471-2458-10-128.
3
Is there an Association between Complementary and Alternative Medicine use and Trust in Physicians in Patients with Rheumatic Diseases?补充和替代医学的使用与风湿性疾病患者对医生的信任之间是否存在关联?
Curr Rheumatol Rev. 2024;20(4):444-450. doi: 10.2174/0115733971271511231220101117.
4
Patient-physician communication about complementary and alternative medicine in a radiation oncology setting.在放射肿瘤学环境中患者与医生关于补充和替代医学的交流。
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e1-6. doi: 10.1016/j.ijrobp.2012.08.018. Epub 2012 Oct 3.
5
Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.安大略省乳腺癌幸存者对补充和替代医学的使用:患病率与认知情况
J Clin Oncol. 2000 Jul;18(13):2515-21. doi: 10.1200/JCO.2000.18.13.2515.
6
Does trust in health care influence the use of complementary and alternative medicine by chronically ill people?对医疗保健的信任会影响慢性病患者对补充和替代医学的使用吗?
BMC Public Health. 2006 Jul 18;6:188. doi: 10.1186/1471-2458-6-188.
7
Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used.男性癌症患者使用补充和替代医学(CAM)的决策:信息寻求角色及所使用的证据类型
BMC Complement Altern Med. 2007 Aug 4;7:25. doi: 10.1186/1472-6882-7-25.
8
Discrepant Views of Oncologists and Cancer Patients on Complementary and Alternative Medicine in a Chinese General Hospital.中国一家综合医院中肿瘤学家与癌症患者对补充替代医学的不同看法。
Integr Cancer Ther. 2018 Jun;17(2):451-457. doi: 10.1177/1534735417725579. Epub 2017 Sep 4.
9
Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.加纳癌症放疗和化疗患者中补充和替代医学使用者的特征及其应用意义:一项横断面研究。
BMC Complement Altern Med. 2013 Jan 19;13:16. doi: 10.1186/1472-6882-13-16.
10
Patterns of complementary and alternative medicine use among Turkish cancer patients.土耳其癌症患者的补充和替代医学使用模式。
J Palliat Med. 2013 Apr;16(4):383-90. doi: 10.1089/jpm.2012.0226. Epub 2013 Jan 10.

引用本文的文献

1
Prevalence and associated factors of herbal medicine use among breast cancer patients: a cross-sectional study in Morocco.摩洛哥乳腺癌患者使用草药的患病率及相关因素:一项横断面研究
Ecancermedicalscience. 2024 Oct 9;18:1786. doi: 10.3332/ecancer.2024.1786. eCollection 2024.
2
Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients.医生和治疗师使用苦杏仁苷治疗癌症患者的调查。
Nutrients. 2024 Jun 28;16(13):2068. doi: 10.3390/nu16132068.
3
Unveiling Patient Trust in Physicians Across China: Insights from a Nationwide Cross-Sectional Study.
揭示中国患者对医生的信任:来自一项全国性横断面研究的见解。
Risk Manag Healthc Policy. 2024 Apr 23;17:1039-1052. doi: 10.2147/RMHP.S456585. eCollection 2024.